1359404
Levetiracetam
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 102767-28-2
Synonym(S): (αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide, 2(S)-(2-Oxopyrrolidin-1-yl)butyramide
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | 1359404-200-MG | In Stock | ₹ 55,846.18 |
1359404 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 55,846.18
GST (18%): ₹ 10,052.312
Total Price: ₹ 65,898.492
grade
pharmaceutical primary standard
API family
levetiracetam
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
CC[C@H](N1CCCC1=O)C(N)=O
InChI
1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
InChI key
HPHUVLMMVZITSG-LURJTMIESA-N
Gene Information
human ... CACNA1B(774) , SV2A(9900)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Apexbio Technology LLC Levetiracetam, 50mg Cas# 102767-28-2 | -- | ₹ 5,340.00 | ||
Levitiracetam Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 14,062.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Levetiracetam United States Pharmacopeia (USP) Reference Standard | 102767-28-2 | MFCD03265610 | 200MG | -- | ₹ 64,167.22 | ||
U.S. Pharmacopeia Levetiracetam, 102767-28-2, MFCD03265610, 200 mg | -- | ₹ 42,193.12 | ||
Levetiracetam | -- | ₹ 11,907.50 | ||
Levetiracetam | -- | ₹ 16,107.60 | ||
102767-28-2 | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide | -- | ₹ 445.00 - ₹ 35,600.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Levetiracetam USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Biochem/physiol Actions: Levetiracetam is a pyrrolidine with antiepileptic activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable